BioStockAddict
RT @kristen_hallam: Benlysta, the drug at the heart of the GSK bid for $HGSI, rejected by UK's NICE even after GSK offered discount.
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.